| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |